Advances in Targeting Cutaneous Melanoma.

Area of Science:

• Oncology
• Dermatology
• Cancer Research

Background:

• Skin cancer, particularly cutaneous melanoma, is prevalent in Caucasians.
• Melanoma can metastasize and develop treatment resistance if not detected early.
• The complex cellular nature of skin contributes to diverse cancer origins.

Purpose of the Study:

• To review the current treatment landscape for cutaneous melanoma.
• To discuss emerging therapeutic agents and combination strategies.
• To highlight advancements in patient-centered melanoma care.

Main Methods:

• Literature review of current and emerging cutaneous melanoma treatments.
• Analysis of established therapies (surgery, radio/chemotherapy).
• Evaluation of novel approaches including immunomodulators, targeted therapies, and oncolytic viruses.

Main Results:

• Established treatments include surgery, radio-, and chemotherapy.
• Emerging therapies involve systemic/intratumoral immunomodulators and targeted agents.
• Combination strategies (e.g., immune checkpoint blockade with targeted therapies) show promise for advanced disease.

Conclusions:

• Diverse and patient-centered treatment options are essential for cutaneous melanoma.
• Combination therapies represent a promising frontier for advanced melanoma management.
• Ongoing research into novel agents and regimens is critical for improving patient outcomes.